With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of the Company at its meeting held today, has inter-alia approved the Unaudited Financial ....
PAUSHAKLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Paushak Limited's Board of Directors approved the unaudited financial results for the quarter ended 30th June 2025. Revenue from operations rose to Rs 5,588 lacs, up about 7.4% from Rs 5,201 lacs in the same quarter last year. Profit before tax grew sharply to Rs 1,563 lacs from Rs 1,245 lacs, a jump of roughly 25%. Profit after tax stood at Rs 1,203 lacs versus Rs 1,031 lacs in Q1 FY25, translating to basic EPS of Rs 39.04 (vs Rs 33.04 last year). The statutory auditors Haribhakti & Co. LLP issued an unqualified limited review report with no qualifications. The company continues to operate in a single segment of speciality chemicals (phosgene derivatives).
Solid double-digit earnings growth on modest revenue rise suggests margin expansion, which is positive for shareholders. The clean auditor report and zero qualifications reinforce confidence in the numbers, though other income fell sharply (Rs 188 lacs vs Rs 416 lacs YoY), indicating core operating performance is the key driver this quarter.